Neuron-specific enolase has potential value as a biomarker for [
FDG PET/CT
Mismatch
PSMA PET/CT
Prostate cancer
mCRPC
Journal
EJNMMI research
ISSN: 2191-219X
Titre abrégé: EJNMMI Res
Pays: Germany
ID NLM: 101560946
Informations de publication
Date de publication:
24 May 2020
24 May 2020
Historique:
received:
21
02
2020
accepted:
04
05
2020
entrez:
26
5
2020
pubmed:
26
5
2020
medline:
26
5
2020
Statut:
epublish
Résumé
PSMA-targeted radioligand therapy (PSMA-RLT) yielded impressive results in the metastasized castration-resistant prostate carcinoma (mCRPC) setting. High expression of PSMA is essential for successful PSMA-RLT. However, some patients develop [ Retrospective study of N = 66 advanced mCRPC patients with dual [ In total, 41/66 (62%) patients revealed at least one [ We observed a significantly higher absolute serum concentration and a higher relative increase of NSE in advanced mCRPC patients with [
Sections du résumé
BACKGROUND
BACKGROUND
PSMA-targeted radioligand therapy (PSMA-RLT) yielded impressive results in the metastasized castration-resistant prostate carcinoma (mCRPC) setting. High expression of PSMA is essential for successful PSMA-RLT. However, some patients develop [
METHODS
METHODS
Retrospective study of N = 66 advanced mCRPC patients with dual [
RESULTS
RESULTS
In total, 41/66 (62%) patients revealed at least one [
CONCLUSION
CONCLUSIONS
We observed a significantly higher absolute serum concentration and a higher relative increase of NSE in advanced mCRPC patients with [
Identifiants
pubmed: 32449086
doi: 10.1186/s13550-020-00640-2
pii: 10.1186/s13550-020-00640-2
pmc: PMC7246282
doi:
Types de publication
Journal Article
Langues
eng
Pagination
52Références
Prostate. 2020 Jan;80(1):17-27
pubmed: 31579967
Nat Rev Cancer. 2015 Dec;15(12):701-11
pubmed: 26563462
Front Oncol. 2015 Apr 14;5:90
pubmed: 25927031
Front Oncol. 2014 Mar 25;4:60
pubmed: 24724054
N Engl J Med. 2004 Oct 7;351(15):1502-12
pubmed: 15470213
Eur J Nucl Med Mol Imaging. 2019 May;46(5):1054-1062
pubmed: 30697649
Ther Adv Med Oncol. 2019 Sep 20;11:1758835919876828
pubmed: 31565073
Eur Urol. 2019 Jun;75(6):920-926
pubmed: 30473431
Lancet Oncol. 2018 Jun;19(6):825-833
pubmed: 29752180
Clin Genitourin Cancer. 2019 Feb;17(1):15-22
pubmed: 30425003
Target Oncol. 2017 Aug;12(4):401-412
pubmed: 28620691
J Clin Oncol. 2008 Jan 10;26(2):242-5
pubmed: 18182665
Endocr Relat Cancer. 2018 Oct 1;26(2):131-146
pubmed: 30400059
N Engl J Med. 2013 Jan 10;368(2):138-48
pubmed: 23228172
Prostate. 2001 Jun 15;48(1):7-15
pubmed: 11391682
Int J Clin Pract. 2011 Nov;65(11):1180-92
pubmed: 21995694
Front Oncol. 2017 Jun 19;7:131
pubmed: 28674679
Mol Imaging. 2018 Jan-Dec;17:1536012118776068
pubmed: 29873291
Nuklearmedizin. 2007;46(6):291-301
pubmed: 18084685
Int J Biol Markers. 2018 Jan;33(1):10-21
pubmed: 28885659
World J Surg Oncol. 2008 Jun 19;6:64
pubmed: 18565231
Eur Urol. 2017 Apr;71(4):630-642
pubmed: 27591931
Oncol Rep. 2008 Dec;20(6):1561-7
pubmed: 19020742
Prostate. 2014 Aug;74(11):1153-9
pubmed: 24913988
Future Oncol. 2018 Oct;14(24):2543-2556
pubmed: 29925281
Clin Nucl Med. 2015 Feb;40(2):e163-6
pubmed: 25275415
Clin Nucl Med. 2018 Apr;43(4):248-249
pubmed: 29474196
Clin Nucl Med. 2018 Oct;43(10):728-734
pubmed: 30059428
Front Oncol. 2015 Mar 03;5:37
pubmed: 25785244
Prostate. 2002 May 1;51(2):117-25
pubmed: 11948966
Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):81-91
pubmed: 27506431
Prostate Cancer Prostatic Dis. 2012 Sep;15(3):283-8
pubmed: 22349984
Clin Cancer Res. 2014 Jun 1;20(11):2846-50
pubmed: 24727321
EJNMMI Res. 2019 Aug 29;9(1):84
pubmed: 31468235
N Engl J Med. 2014 Jul 31;371(5):424-33
pubmed: 24881730
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1014-1024
pubmed: 28283702
Crit Rev Clin Lab Sci. 2001 Aug;38(4):263-355
pubmed: 11563810
Nature. 1978 Dec 21-28;276(5690):834-6
pubmed: 31568
J Nucl Med. 2016 Oct;57(Suppl 3):79S-89S
pubmed: 27694178
Prostate Cancer Prostatic Dis. 2020 Jan 13;:
pubmed: 31932660
Prostate. 2011 May;71(6):642-8
pubmed: 20945407
Eur Urol Oncol. 2019 Nov;2(6):670-676
pubmed: 31412006
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2536-2544
pubmed: 31440799
Adv Exp Med Biol. 2015;867:125-43
pubmed: 26530364
Clin Genitourin Cancer. 2017 Feb;15(1):e65-e68
pubmed: 27751686
J Nucl Med. 2017 Aug;58(8):1196-1200
pubmed: 28663195
J Natl Compr Canc Netw. 2014 May;12(5):719-26
pubmed: 24812138
Clin Nucl Med. 2017 May;42(5):410-413
pubmed: 28240661
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593